Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
Week In Review: GenFleet Out-Licenses Three Candidates To Verastem In $625 Million Deal
September 02, 2023
From TalkMarkets
The Truth About IPO Investing
September 02, 2023
From TalkMarkets
August Recap: Largest Psychedelic Compound-Based R & D Stocks Down 15%
September 02, 2023
From TalkMarkets
From TalkMarkets
From TalkMarkets
Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca
August 26, 2023
From TalkMarkets
6 Largest Psychedelic Compound-Based R&D Stocks Continued Downwards, On Average, This Week
August 25, 2023
From TalkMarkets
Tuesday Talk: Monday Rebound
August 22, 2023
From TalkMarkets
Gene Therapy Breakthroughs On The Horizon
August 21, 2023
From TalkMarkets
Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner
August 21, 2023
From TalkMarkets
From TalkMarkets
Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal
August 19, 2023
From TalkMarkets
How To Invest In The Healthcare Sector
August 19, 2023
From TalkMarkets
Thoughts For Thursday: Slipsliding, Sideways
August 17, 2023
From TalkMarkets
So Far, August Isn't Kind To 4 Of 6 Constituents In Our Psychedelic Drug Stocks Index
August 13, 2023
From TalkMarkets
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
August 12, 2023
From TalkMarkets
From TalkMarkets
S&P 500 Forecast: Resilience In Earnings Season
August 02, 2023
From TalkMarkets
Arnold Pharmaceuticals Sprints To Nasdaq
August 02, 2023
From TalkMarkets
Correction In August?
August 01, 2023
From TalkMarkets
The Canadian Cannabis Report- Monday, July 31
July 31, 2023
From TalkMarkets
From TalkMarkets
From TalkMarkets
Big Weeks Ahead For MedTech And Life Science Stocks
July 24, 2023
From TalkMarkets
Tickers
GILD
From TalkMarkets
From TalkMarkets
From TalkMarkets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.